Gossamer Bio
Hospitals and Health Care
Science Seralutinib Seralutinib is an inhaled PDGFRα/β, CSF1R, and c‑KIT inhibitor designed to be delivered via dry powder inhaler for the potential treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
Is Gossamer Bio hiring?
Yes. As of October 28, 2026, Gossamer Bio has 1 open role on Metaintro.
Open roles
Newest first. Pay shown when the posting lists it.
Hiring pattern
How fast Gossamer Bio is adding roles, and how they're set up.
New roles each monthRoles first posted in the month
1
0
SeptemberOctober
Skills they ask for
Most frequent across open postings.
Tech stack
- CMS
- WordPress
- Analytics
- Google Analytics 4
- Google Tag Manager
- Libraries
- Font Awesome
- jQuery
Company facts
- Founded
- 2015
- Industry
- Hospitals and Health Care
- Sector (NAICS)
- Professional, Scientific, and Technical Services
- Ticker
- GOSS
- Peer
- CVS Health
- Website
- gossamerbio.com
Sources: Founded from Wikidata
Similar companies
Companies in the same industry as Gossamer Bio that are hiring now.